273 related articles for article (PubMed ID: 19155494)
1. Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis.
Strauss L; Bergmann C; Whiteside TL
J Immunol; 2009 Feb; 182(3):1469-80. PubMed ID: 19155494
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal granzyme/perforin-mediated death of human regulatory and responder T cells is regulated by interleukin-2 (IL-2).
Czystowska M; Strauss L; Bergmann C; Szajnik M; Rabinowich H; Whiteside TL
J Mol Med (Berl); 2010 Jun; 88(6):577-88. PubMed ID: 20225066
[TBL] [Abstract][Full Text] [Related]
3. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
[TBL] [Abstract][Full Text] [Related]
4. Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.
Strauss L; Bergmann C; Szczepanski MJ; Lang S; Kirkwood JM; Whiteside TL
J Immunol; 2008 Mar; 180(5):2967-80. PubMed ID: 18292519
[TBL] [Abstract][Full Text] [Related]
5. Functional and phenotypic characteristics of CD4+CD25highFoxp3+ Treg clones obtained from peripheral blood of patients with cancer.
Strauss L; Bergmann C; Whiteside TL
Int J Cancer; 2007 Dec; 121(11):2473-83. PubMed ID: 17691114
[TBL] [Abstract][Full Text] [Related]
6. Activated CD8+ T-effector/memory cells eliminate CD4+ CD25+ Foxp3+ T-suppressor cells from tumors via FasL mediated apoptosis.
Kilinc MO; Rowswell-Turner RB; Gu T; Virtuoso LP; Egilmez NK
J Immunol; 2009 Dec; 183(12):7656-60. PubMed ID: 19923444
[TBL] [Abstract][Full Text] [Related]
7. The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck.
Strauss L; Bergmann C; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2007 Nov; 13(21):6301-11. PubMed ID: 17975141
[TBL] [Abstract][Full Text] [Related]
8. FAS/FAS-L dependent killing of activated human monocytes and macrophages by CD4+CD25- responder T cells, but not CD4+CD25+ regulatory T cells.
Jagger AL; Evans HG; Walter GJ; Gullick NJ; Menon B; Ballantine LE; Gracie A; Magerus-Chatinet A; Tiemessen MM; Geissmann F; Rieux-Laucat F; Taams LS
J Autoimmun; 2012 Feb; 38(1):29-38. PubMed ID: 22197557
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic and functional characteristics of CD4+ CD39+ FOXP3+ and CD4+ CD39+ FOXP3neg T-cell subsets in cancer patients.
Schuler PJ; Schilling B; Harasymczuk M; Hoffmann TK; Johnson J; Lang S; Whiteside TL
Eur J Immunol; 2012 Jul; 42(7):1876-85. PubMed ID: 22585562
[TBL] [Abstract][Full Text] [Related]
10. CD4+ CD25+ Foxp3+ IFNγ+ CD178+ human induced Treg (iTreg) contribute to suppression of alloresponses by apoptosis of responder cells.
Daniel V; Sadeghi M; Wang H; Opelz G
Hum Immunol; 2013 Feb; 74(2):151-62. PubMed ID: 23017670
[TBL] [Abstract][Full Text] [Related]
11. Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin.
Strauss L; Czystowska M; Szajnik M; Mandapathil M; Whiteside TL
PLoS One; 2009 Jun; 4(6):e5994. PubMed ID: 19543393
[TBL] [Abstract][Full Text] [Related]
12. Suppression of allograft rejection by CD8+CD122+PD-1+ Tregs is dictated by their Fas ligand-initiated killing of effector T cells versus Fas-mediated own apoptosis.
Liu H; Wang Y; Zeng Q; Zeng YQ; Liang CL; Qiu F; Nie H; Dai Z
Oncotarget; 2017 Apr; 8(15):24187-24195. PubMed ID: 28445940
[TBL] [Abstract][Full Text] [Related]
13. Expression of Fas/FasL in CD8+ T and CD3+ Foxp3+ Treg cells--relationship with apoptosis of circulating CD8+ T cells in hepatocellular carcinoma patients.
Guo CL; Yang XH; Cheng W; Xu Y; Li JB; Sun YX; Bi YM; Zhang L; Wang QC
Asian Pac J Cancer Prev; 2014; 15(6):2613-8. PubMed ID: 24761872
[TBL] [Abstract][Full Text] [Related]
14. Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2.
Berntsen A; Brimnes MK; thor Straten P; Svane IM
J Immunother; 2010 May; 33(4):425-34. PubMed ID: 20386464
[TBL] [Abstract][Full Text] [Related]
15. Low circulating CD4(+) CD25(+) Foxp3(+) T regulatory cell levels predict miscarriage risk in newly pregnant women with a history of failure.
Winger EE; Reed JL
Am J Reprod Immunol; 2011 Oct; 66(4):320-8. PubMed ID: 21314851
[TBL] [Abstract][Full Text] [Related]
16. Transient local depletion of Foxp3+ regulatory T cells during recovery from colitis via Fas/Fas ligand-induced death.
Reardon C; Wang A; McKay DM
J Immunol; 2008 Jun; 180(12):8316-26. PubMed ID: 18523298
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: CD4+ T cells kill CD8+ T cells via Fas/Fas ligand-mediated apoptosis.
Piazza C; Gilardini Montani MS; Moretti S; Cundari E; Piccolella E
J Immunol; 1997 Feb; 158(4):1503-6. PubMed ID: 9029083
[TBL] [Abstract][Full Text] [Related]
18. Increased frequency and suppressive activity of CD127(low/-) regulatory T cells in the peripheral circulation of patients with head and neck squamous cell carcinoma are associated with advanced stage and nodal involvement.
Drennan S; Stafford ND; Greenman J; Green VL
Immunology; 2013 Nov; 140(3):335-43. PubMed ID: 23826668
[TBL] [Abstract][Full Text] [Related]
19. Equine CD4(+) CD25(high) T cells exhibit regulatory activity by close contact and cytokine-dependent mechanisms in vitro.
Hamza E; Gerber V; Steinbach F; Marti E
Immunology; 2011 Nov; 134(3):292-304. PubMed ID: 21977999
[TBL] [Abstract][Full Text] [Related]
20. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]